Anagallis Arvensis

Anagallis arvensis  Linn.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Primulaceae.
Habitat Northwestern Himalayas from Kashmir eastwards to Nepal, hills of West Bengal; Central and southern India.
English Bird’s Eye, Bird’s Tongue, Blue Pimpernel, Scarlet Pimpernel.
Unani Anaaghaalis.
Folk Jonkmaari (Maharashtra), Dhabbar (Punjab), Jighanaa, Jenghani.
Action Plant—anti-inflammatory, astringent, deobstructant, antifungal, nematocidal; toxic to leeches.
Taxonomic Cohort Genus Anagallis (1 documented species); Family Primulaceae (3 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Anagallis arvensis (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Primulaceae (primary family classification: Primulaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Northwestern Himalayas from Kashmir eastwards to Nepal, hills of West Bengal; Central and southern India.

Across classical and vernacular Indian systems of medicine, Anagallis arvensis is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Bird’s Eye, Bird’s Tongue, Blue Pimpernel, Scarlet Pimpernel; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Anaaghaalis; in regional Indian folk and vernacular ethnobotany as Jonkmaari (Maharashtra), Dhabbar (Punjab), Jighanaa, Jenghani. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Anagallis arvensis are: Plant—anti-inflammatory, astringent, deobstructant, antifungal, nematocidal; toxic to leeches. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Anagallis arvensis establish the following evidence base: The plant yields anagalligenone B. The presence of quaternary alkaloids, gluco-fructoside and tannin have been reported. The root yields glycosidic saponins, including cyclamin. An acetyl saponin, isolated from the plant, was found to possess marked taenicidal activity but had no effect on roundworms. A methanolic extract of the aerial parts showed activity against herpes simplex I, adenovirus type II and polio type II. Triterepene saponins have oestrogenic activity.

image2

Botanical Reference 1: Lysimachia arvensis — Botanical specimen

image3

Botanical Reference 2: Lysimachia arvensis — Botanical specimen

image4

Botanical Reference 3: Anagallis arvensis — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Anagallis arvensis stands as a distinct representative of the genus Anagallis. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Primulaceae encompasses 3 documented medicinal species (0.17% of the 1,814-species flora). Other representative medicinal members of Primulaceae include: Primula denticulata (Keechey), Primula vulgaris (Primrose). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 3 medicinal species of family Primulaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Anagallis arvensis follow the plant-part modalities specified under its therapeutic action (Plant—anti-inflammatory, astringent, deobstructant, antifungal, nematocidal; toxic to leeches), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Anagallis arvensis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top